Open access · CC-BY
via OpenAlex
Epigenomic Rejuvenation Without Functional Restoration
Longevity Horizon · 2026
Epigenetic alterations
Partial reprogramming (OSK)
Human
Mouse
Systematic review
Preclinical / animal
Meta-analysis
Review
Abstract
Background: Partial reprogramming(definition) using Yamanaka factors (OSKM) reverses epigenetic age (DNAmAge) in preclinical models. However, whether this molecular shift translates into functional physiological improvement remains unresolved. The “damage shadow” hypothesis posits that structural lesions accumulate with age that are not correctable by epigenetic reset alone. Methods: Pre-registered systematic review and meta-analysis (PROSPERO CRD42026218473) following PRISMA-2020. Searched PubMed, Scopus, Web of Science, bioRxiv (January 2020–April 2026) for partial reprogramming studies in aged mammals (>18 months for mice) with concurrent DNAmAge and systemic functional outcomes. Risk of bias: ROBINS-I. Analysis: meta-regression with restricted cubic splines, piecewise linear models, publication bias assessment (Egger’s test, trim-and-fill, selection model). Findings: Of 847 records, 14 studies (n=274 animals) met criteria. Meta-analysis revealed no significant linear association between ΔDNAmAge and systemic functional improvement (Fisher’s Z = 0.09; 95% CI: -0.14 to 0.32; p = 0.44), with substantial heterogeneity (I² = 78%; 95% CI: 58-89%). Non-linear modeling identified a threshold (ΔDNAmAge ≈ -2.4 years-equivalent), above which modest functional gains emerged only in tissue-specific contexts. GrimAge-based clocks showed stronger functional associations than Horvath or PhenoAge clocks. Tissue-specific outcomes in acute injury models (Lu et al., 2020) and engram neuron reprogramming (Berdugo-Vega et al., 2026) represented distinct contexts not generalizable to systemic aging. Evidence of publication bias was detected (Egger’s test p = 0.04), suggesting overestimation of reported effects. Interpretation: DNAmAge reversal through partial reprogramming does not translate into commensurate systemic functional improvement in naturally aged organisms. The “damage shadow”—comprising collagen cross-linking, mtDNA mutations, and nuclear non-epimutation damage—appears to constitute an epigenetically-independent barrier to functional rejuvenation. Notable exceptions in highly plastic cell populations (RGCs, engram neurons) refine rather than refute this conclusion.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.65649/6ms1pc75
- Canonical
- link ↗
- Fetched
- 2026-11-14 MST
Cite this
APA
Yao, M. (2026). Epigenomic Rejuvenation Without Functional Restoration. <em>Longevity Horizon</em>. https://doi.org/10.65649/6ms1pc75
Vancouver
Yao M. Epigenomic Rejuvenation Without Functional Restoration. Longevity Horizon. 2026. doi:10.65649/6ms1pc75.
BibTeX
@article{ming2026Epigen,
title = {Epigenomic Rejuvenation Without Functional Restoration},
author = {Ming Yao},
journal = {Longevity Horizon},
year = {2026},
doi = {10.65649/6ms1pc75},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
bioRxiv (Cold Spring Harbor Laboratory) 2025
Preprint · CC-BY
Deep and Quantitative Proteomic Profiling of Low Volume Mouse Serum Across the Lifespan
Ageing and Cancer Research & Treatment 2026
Open access · CC-BY
Selective preservation of immune competence in human longevity: Youth-like cellular features and molecular support programs
Ageing Research Reviews 2021
Open access · CC-BY
Stress and telomere shortening: Insights from cellular mechanisms
The Journals of Gerontology Series A 2021
Open access · CC-BY
The Association Between Epigenetic Clocks and Physical Functioning in Older Women: A 3-Year Follow-up
Nature Communications 2025
Open access · CC-BY
Senescent-like microglia limit remyelination through the senescence associated secretory phenotype
Pakistan Journal of Medical & Cardiological Review 2026
Open access · OA